1.
Infect Control Hosp Epidemiol
; 44(7): 1171-1173, 2023 Jul.
Article
in English
| MEDLINE
| ID: mdl-36951472
ABSTRACT
We studied 83 cardiac-surgery patients with nasal S. aureus carriage who received 4 intranasal administrations of XF-73 nasal gel or placebo <24 hours before surgery. One hour before surgery, patients exhibited a S. aureus nasal carriage reduction of 2.5 log10 with XF-73 compared to 0.4 log10 CFU/mL for those who received placebo (95% CI, -2.7 to -1.5; P < .0001).
Subject(s)
Cardiac Surgical Procedures , Staphylococcal Infections , Humans , Staphylococcus aureus , Chlorides/therapeutic use , Anti-Bacterial Agents/therapeutic use , Nose , Staphylococcal Infections/drug therapy , Cardiac Surgical Procedures/adverse effects , Carrier State/drug therapy
2.
Ann Thorac Surg
; 107(2): 619-630, 2019 02.
Article
in English
| MEDLINE
| ID: mdl-30500341